In recent weeks, respiratory syncytial virus (RSV) circulation in the EU/EEA has intensified, with increasing transmission rates in all population groups and an earlier-than-usual start of the season. Several EU/EEA countries are experiencing high RSV circulation and the number of severe acute respiratory infections (SARI) due to RSV is increasing. At this time of the year RSV infections are not unusual, however this year there is more RSV activity and it began earlier than in pre-COVID-19 seasons.
This situation update for seasonal influenza uses epidemiological and virological data to assess the seasonal increase of influenza cases in relation to disease severity and impact on healthcare systems. It is designed to assist forward planning in Member States.
First detections indicated circulation of A(H3N2) and B/Yamagata viruses. As the former subtype dominated last season, a high proportion of the population should be protected.
Since the notification of a novel reassortant influenza A(H7N9) virus on 31 March 2013, 1 548 laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus have been reported.
This rapid risk assessment builds on the fifth update of the ECDC rapid risk assessments on avian influenza published on 27 January 2017 [1] and on the recent public health development dated 24 February 2017.
Fifth update of the risk assessment on human infection with avian influenza A(H7N9) virus, summarising the epidemiological and virological information on the disease in China and Canada, and assessing the risk to public health in the EU/EEA.
Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
This risk assessment summarises the development of the 2015–16 influenza season, which so far has been characterised by a prevalence of type A viruses.